NCT05390372

Brief Summary

The population of the research will be preterm infants born 35-36 weeks of gestation, hospitalized in the Neonatal Intensive Care Unit of Karaman State Hospital, whose skin is damaged due to Intravenous (IV) vascular access fixation bands, and whose skin has not been subjected to any other application before. Calculation of the sample number of the research; It was determined that at least 24 newborns should be assigned to each group (α = 0.05 and β = 0.19) to show that the 1 degree difference between the cream group and the breast milk group was significant for 80.7% strength. It is planned to take a premature baby. As data collection tools, Premature Babies Descriptive Information Form, Newborn Skin Condition Assessment Scale, Medical Adhesives and Solvents Used in the Neonatal Intensive Care Unit, Human Milk and routine care will be used.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
36

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Aug 2022

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 11, 2022

Completed
14 days until next milestone

First Posted

Study publicly available on registry

May 25, 2022

Completed
2 months until next milestone

Study Start

First participant enrolled

August 1, 2022

Completed
26 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 27, 2022

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2022

Completed
Last Updated

March 28, 2023

Status Verified

March 1, 2023

Enrollment Period

26 days

First QC Date

May 11, 2022

Last Update Submit

March 24, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • skin damage

    The change in skin damage after the intervention with newborn skin condition assessment scalewill be monitored.

    3 weeks

Study Arms (2)

humanmilk

EXPERIMENTAL

For skin damage care of preterm newborns randomly assigned to the breast milk group, their own breast milk will be applied topically once every 60 minutes until complete healing. Skin damage in newborns will be evaluated by an independent nurse and specialist doctor for 60 minutes during the treatment, and the score will be given and recorded. A minimum decrease of 1 point in the skin condition assessment scale score will be considered to indicate 'improvement'. The decision that the skin integrity of the newborn is completely healed will be made by the neonatal doctor independent of the trial. Areas between 0-3 on the newborn skin condition assessment scale will be considered healed. Breastfeeding does not have any side effects in preterm newborns.

Other: human milk

routine care group

EXPERIMENTAL

cream applied as part of hospital routine practice

Other: Routine care group

Interventions

For skin damage care of preterm newborns randomly assigned to the breast milk group, their own breast milk will be applied topically once every 60 minutes until complete healing. Skin damage in newborns will be evaluated by an independent nurse and specialist doctor for 60 minutes during the treatment, and the score will be given and recorded. A minimum decrease of 1 point in the skin condition assessment scale score will be considered to indicate 'improvement'. The decision that the skin integrity of the newborn is completely healed will be made by the neonatal doctor independent of the trial. Areas between 0-3 on the newborn skin condition assessment scale will be considered healed. Breastfeeding does not have any side effects in preterm newborns.

humanmilk

cream applied as part of hospital routine practice

routine care group

Eligibility Criteria

Age1 Day - 30 Days
Sexall(Gender-based eligibility)
Gender Eligibility Detailspreterm newborns
Healthy VolunteersYes
Age GroupsChild (0-17)

You may qualify if:

  • Written and verbal consent of the parents,
  • The newborn is less than 37 weeks of gestation,
  • Being in the Neonatal Intensive Care Unit,
  • The intravenous catheter has been fixed to the skin with a silk patch,
  • For intravenous catheter fixation, the bands remain on the skin for a minimum of 24 hours and a maximum of 32 hours,
  • While removing the adhesive tape, remove it slowly and carefully by softening the tape with cotton moistened with water,
  • The parent speaks and understands Turkish comfortably,
  • Stable health status
  • Having spontaneous breathing
  • Not being exposed to a painful procedure at least half an hour before the interventions.
  • Not taking opioid or non-opioid analgesics
  • Not receiving any antibiotic treatment,
  • Having breast milk

You may not qualify if:

  • Parent's inability to speak and understand Turkish easily,
  • Parents do not give written and verbal consent,
  • Intravenous catheter not fixed to the skin with a silk patch,
  • For intravenous catheter fixation, the bands should not remain on the skin for a minimum of 24 hours and a maximum of 32 hours,
  • Removal of the intravenous catheter from the skin using a solvent solution,
  • Having ventilator support
  • Presence of congenital anomaly
  • Using analgesic / narcotic analgesic drugs
  • Receiving any antibiotic treatment,
  • Continuous sedative treatment
  • Discontinuation of topical breast milk or cream application procedure for any reason
  • Parent's wish to leave the study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ayşe Sonay Türkmen

Karaman, 70100, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Breast Milk Expression

Interventions

Milk, Human

Condition Hierarchy (Ancestors)

Breast FeedingFeeding BehaviorBehavior

Intervention Hierarchy (Ancestors)

MilkBeveragesDiet, Food, and NutritionPhysiological PhenomenaDairy ProductsFoodFood and Beverages

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
OTHER
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Prof.Dr

Study Record Dates

First Submitted

May 11, 2022

First Posted

May 25, 2022

Study Start

August 1, 2022

Primary Completion

August 27, 2022

Study Completion

November 1, 2022

Last Updated

March 28, 2023

Record last verified: 2023-03

Data Sharing

IPD Sharing
Will not share

Locations